Amphastar Pharmaceuticals's total assets for Q3 2024 were $1.55B, an increase of 3.60% from the previous quarter. AMPH total liabilities were $817.50M for the fiscal quarter, a 5.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.